IA Trial Radar
L'essai clinique NCT07385534 (LB-EMS-PMW) pour Sarcopénie, Artériosclérose, Arterial Stiffness, Blood Pressure, Femmes post-ménopausiques est en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici.
Un essai clinique correspond aux filtres sélectionnés
Vue en carte
Retour à la recherche

Effects of Lower Body EMS Training in Postmenopausal Women (LB-EMS-PMW) 39 Randomisé Exercice

En recrutement
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'étude' pour voir et discuter des informations sur l'étude dans la langue sélectionnée.
L'essai clinique NCT07385534 (LB-EMS-PMW) est une étude interventionnel pour Sarcopénie, Artériosclérose, Arterial Stiffness, Blood Pressure, Femmes post-ménopausiques. Son statut actuel est : en recrutement. L'étude a débuté le 26 décembre 2025 et vise à recruter 39 participants. Dirigée par l'Université nationale de Séoul, l'étude devrait être terminée d'ici le 26 mai 2026. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 4 février 2026.
Résumé succinct
This study evaluates the effects of a 6-week lower body Electrical Muscle Stimulation (EMS) training program on body composition, muscle function, and arteriosclerosis markers in postmenopausal women.

Menopause is associated with a rapid decline in estrogen, which increases the risk of sarcopenia (muscle loss) and arterial stiffness (cardiovascular disease). While resistance training is effective for these condition...

Afficher plus
Titre officiel

Effects of Lower Body Electrical Muscle Stimulation Training on Body Composition, Muscle Function, and Arteriosclerosis Markers in Postmenopausal Women

Pathologies
SarcopénieArtérioscléroseArterial Stiffness, Blood PressureFemmes post-ménopausiques
Autres identifiants de l'étude
  • LB-EMS-PMW
  • IRB No. 2601/002-017
Numéro NCT
NCT07385534
Date de début (réel)
2025-12-26
Dernière mise à jour publiée
2026-02-04
Date de fin (estimée)
2026-05-26
Inscription (estimée)
39
Type d'étude
Interventionnel
PHASE
N/A
Statut
En recrutement
Mots clés
Electrical Muscle Stimulation
EMS
Resistance Training
Postmenopausal Women
Body Composition
Vascular Health
Muscle Function
Objectif principal
Prévention
Méthode d'allocation
Randomisé
Modèle d'intervention
Parallèle
Masquage
Aucun (ouvert)
Bras / Interventions
Groupe de participants/BrasIntervention/Traitement
ExpérimentalLower Body EMS + Resistance Training Group
Participants perform lower body resistance training while wearing a lower body EMS suit. Each session lasts 50 minutes (10-min warm-up, 30-min main exercise, 10-min cool-down). EMS stimulation is applied exclusively during the 30-minute main exercise phase (85Hz, 350µs). This program is conducted twice a week for 6 weeks.
Lower-body Electromyostimulation (LB-EMS) device
Electrical stimulation applied to the lower body muscles (85Hz, 350µs) during the main exercise phase
Lower Body Resistance Training
A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main lower body resistance training (4 types of machine-based exercises per session), and a 10-minute cool-down
Comparateur actifResistance Training Only Group
Participants perform the identical lower body resistance training program without EMS stimulation. The session structure (10-min warm-up, 30-min main exercise, 10-min cool-down) and total duration (50 minutes) are the same as the experimental group.
Lower Body Resistance Training
A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main lower body resistance training (4 types of machine-based exercises per session), and a 10-minute cool-down
Aucune interventionControl Group
Participants maintain their usual daily lifestyle without engaging in any new exercise programs during the 6-week study period.
N/A
Critère principal d'évaluation
Critères d'évaluationDescription de la mesurePériode
Brachial-ankle Pulse Wave Velocity (baPWV)
An indicator of arterial stiffness. Higher values indicate stiffer arteries. Unit of Measure: cm/s
Baseline and Week 6
Critère secondaire d'évaluation
Critères d'évaluationDescription de la mesurePériode
Ankle-Brachial Index (ABI)
The Ankle-Brachial Index (ABI) is the ratio of the systolic blood pressure measured at the ankle to the systolic blood pressure measured at the brachial artery. It is a non-invasive indicator used to assess the presence and severity of peripheral arterial stenosis or occlusion. Lower ABI values (typically \< 0.9) suggest narrowing or blockage of the arteries in the legs. Unit of Measure: ratio
Baseline and Week 6
Skeletal Muscle Mass
Assessed using Bioelectrical Impedance Analysis (BIA). Represents the total weight of muscle tissue attached to the skeleton. Unit of Measure: kg
Baseline and Week 6
Total Body Fat Mass
Assessed using BIA. Represents the total weight of adipose tissue in the body. Unit of Measure: kg
Baseline and Week 6
Body Fat Percentage
Assessed using BIA. The proportion of fat mass relative to total body weight. Unit of Measure: %
Baseline and Week 6
Extracellular Water to Total Body Water Ratio (ECW/TBW)
Assessed using BIA. An indicator of body fluid balance and edema. Higher values may indicate fluid retention or inflammation. Unit of Measure: ratio
Baseline and Week 6
Skeletal Muscle Mass Index (SMI)
Calculated as appendicular skeletal muscle mass (ASM) divided by height squared (kg/m\^2). Used to assess sarcopenia status. Unit of Measure: kg/m\^2
Baseline and Week 6
Phase Angle
Assessed by BIA. It reflects cellular membrane integrity and nutritional status. Higher values generally indicate better cellular health. Unit of Measure: degree
Baseline and Week 6
Pre-ejection Period (PEP)
Time interval from the onset of ventricular depolarization (QRS complex) to the beginning of ejection. Reflects myocardial contractility. Unit of Measure: ms
Baseline and Week 6
Left Ventricular Ejection Time (ET)
The duration of blood flow ejection from the left ventricle into the aorta. Unit of Measure: ms
Baseline and Week 6
Heart Rate Corrected Ejection Time (ETc)
Ejection time adjusted for heart rate, typically using Bazett's formula. Unit of Measure: ms
Baseline and Week 6
Upstroke Time (UT)
Time from the foot to the peak of the pulse volume waveform. A marker for arterial stiffness or stenosis. Unit of Measure: ms
Baseline and Week 6
ET/PEP Ratio
The ratio of ejection time (ET) to pre-ejection period (PEP). An index of left ventricular performance and efficiency. Unit of Measure: ratio
Baseline and Week 6
Percent Mean Arterial Pressure (%MAP)
The position of mean arterial pressure relative to the pulse pressure range. Used as an indicator of the pulse wave shape and vascular aging. Unit of Measure: %
Baseline and Week 6
Mean Arterial Pressure (MAP)
The average pressure in a patient's arteries during one cardiac cycle. Unit of Measure: mmHg
Baseline and Week 6
Pulse Pressure (PP)
The difference between systolic and diastolic blood pressure. It is a marker of arterial stiffness. Unit of Measure: mmHg
Baseline and Week 6
Peak Torque (Knee Extension/Flexion)
The maximum torque produced during isokinetic knee extension and flexion. Assessed at a 60°/s angular velocity. Unit of Measure: Nm (Newton-meters)
Baseline and Week 6
Total Work Done
The total amount of work performed by the muscle groups during the test protocol at an angular velocity of 180°/s. Unit of Measure: Nm
Baseline and Week 6
Fatigue Index
The percentage decline in peak torque calculated from the difference between the initial and final repetitions during a set of isokinetic contractions performed at an angular velocity of 180°/s. Unit of Measure: %
Baseline and Week 6
Hamstring-Quadriceps Ratio (H/Q Ratio)
The ratio of the peak torque of the hamstring muscles to the peak torque of the quadriceps muscles measured at an angular velocity of 60°/s. Unit of Measure: ratio
Baseline and Week 6
Bilateral Deficit
The percentage difference between the sum of peak torques produced by each leg individually and the peak torque produced when both legs act simultaneously, measured at an angular velocity of 60°/s. Unit of Measure: %
Baseline and Week 6
Assistant à la participation
Critères d'éligibilité

Âges éligibles
Adulte, Adulte âgé
Âge minimum
50 Years
Sexes éligibles
Femme
Accepte les volontaires en bonne santé
Oui
  • Post-menopausal women (defined as cessation of menstruation for at least 12 months).
  • Aged between 50 and 70 years.
  • Sedentary lifestyle (no participation in regular resistance training programs within the last 6 months).
  • Able to perform lower body resistance exercise with LB-EMS suit.
  • Willing to participate in the study and provide informed consent.

  • Contraindications for WB-EMS: Presence of implanted electrical devices (e.g., pacemakers, defibrillators), severe bleeding disorders (e.g., hemophilia), abdominal/inguinal hernia, or history of surgery within the last 6 months (including stent insertion).
  • Severe Chronic Diseases: Diagnosis of severe cardiovascular (e.g., MI, heart failure, arrhythmia), renal, neurological (e.g., epilepsy), or oncological diseases (currently undergoing treatment).
  • Uncontrolled Cardiovascular Conditions: Uncontrolled hypertension or severe arterial circulatory disorders.
  • Confounding Medications: Current use of hormone replacement therapy (HRT) for menopause or medications for severe psychiatric disorders (e.g., depression, anxiety).
  • Acute Conditions & Others: Acute infection/inflammation, influence of alcohol/drugs, or any other condition deemed unsuitable by the investigator.
Seoul National University logoUniversité nationale de Séoul
Partie responsable de l'étude
Kyungho Kim, Investigateur principal, Principal Investigator, Seoul National University
Contact central de l'étude
Contact: Kyungho Kim, MS, 82 + 010-3589-8202, [email protected]
1 Centres de l'étude dans 1 pays

Seoul

Seoul National University, Seoul, Seoul, 08826, South Korea
Kyungho Kim, MS, Contact, 82 + 010-3589-8202, [email protected]
En recrutement